LIBRETTO-432: A phase 3 study of adjuvant selpercatinib or placebo in stage IB-IIIA RET fusion-positive (RET plus ) NSCLC.

被引：0

作者：

Goldman, Jonathan W.

Sands, Jacob

Hallqvist, Andreas

Kim, Hye Ryun

Li, Guoping

Wu, Lin

Su, Weiji

Bayt, Theresa

Yang, Xue-Ning

Hochmair, Maximilian

机构：

[1] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA USA

[2] Dana Farber Canc Inst, Boston, MA USA

[3] Sahlgrens Univ Hosp, Inst Clin Sci, Dept Oncol, Gothenburg, Sweden

[4] Yonsei Univ, Div Med Oncol, Yonsei Canc Ctr, Coll Med, Seoul, South Korea

[5] Third Peoples Hosp Chengdu, Chengdu Inst Resp Hlth, Branch Natl Clin Res Ctr Resp Dis, Chengdu, Peoples R China

[6] Hunan Canc Hosp, Thorac Internal Med Oncol Dept, Changsha, Hunan, Peoples R China

[7] Eli Lilly & Co, Indianapolis, IN USA

[8] Eil Lilly & Co, Indianapolis, IN USA

[9] Southern Med Univ, Guangdong Lung Canc Inst, Guangdong Prov Peoples Hosp, Guangdong Acad Med Sci, Guangzhou, Peoples R China

[10] Klin Floridsdorf, Karl Landsteiner Inst Lung Res & Pulm Oncol, Dept Resp & Crit Care Med, Vienna, Austria

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

TPS8115

引用

页数：1

共 50 条

[21] IMpower010: results from Asian patients in a phase 3 study of adjuvant atezolizumab in resected stage IB-IIIA NSCLC [J].

Kenmotsu, Hirotsugu ;

Zhou, Caicun ;

Altorki, Nasser ;

Felip, Enriqueta ;

Vallieres, Eric ;

Sugawara, Shunichi ;

Sakai, Hiroshi ;

Saito, Haruhiro ;

Tao, Min ;

Kawaguchi, Koji ;

Liu, Yunpeng ;

Yu, Chong-Jen ;

Wu, Qiong ;

Lin, Huang ;

Wu, Fan ;

Bennett, Elizabeth ;

Mcnally, Virginia ;

Gitlitz, Barbara ;

Wakelee, Heather .

ANNALS OF ONCOLOGY, 2022, 33 :S464-S464

[22] Intracranial Activity of Selpercatinib in Chinese Patients With Advanced RET Fusion-Positive Non-Small-Cell Lung Cancer in the Phase II LIBRETTO-321 Trial [J].

Cheng, Ying ;

Huang, Dingzhi ;

Zhou, Jianying ;

Zhou, Chengzhi ;

Sun, Yuping ;

Wu, Lin ;

Guo, Ye ;

Shao, Jingxin ;

Zhang, Wanli ;

Lu, Shun .

JCO PRECISION ONCOLOGY, 2023, 7

[23] Efficacy and safety of selpercatinib in Chinese patients with advanced RET fusion-positive non-small-cell lung cancer: a phase II clinical trial (LIBRETTO-321) [J].

Lu, Shun ;

Cheng, Ying ;

Huang, Dingzhi ;

Sun, Yuping ;

Wu, Lin ;

Zhou, Chengzhi ;

Guo, Ye ;

Shao, Jingxin ;

Zhang, Wanli ;

Zhou, Jianying .

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14

[24] MAGRIT phase III trial: MAGE-A3 antigen-specific cancer immunotherapy (ASCI) as adjuvant therapy in patients with completely resected stage IB-IIIA NSCLC. [J].

Therasse, P. ;

Vansteenkiste, J. F. ;

Zielinski, M. ;

De Pas, T. M. ;

Atanackovic, D. ;

Sequist, L. V. ;

Vallieres, E. ;

Swisher, S. ;

Adams, S. ;

Passlick, B. ;

Eberhardt, W. E. E. ;

Grunenwald, D. ;

Mok, T. ;

Boyer, M. ;

Katz, A. ;

Douillard, J. ;

Debois, M. ;

Brichard, V. G. ;

Altorki, N. K. .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)

[25] Sites of relapse and subsequent therapy in the BR.31 phase study of durvalumab vs placebo in resected stage IB-IIIA NSCLC [J].

Westeel, V. ;

Goss, G. ;

Darling, G. ;

Nakagawa, K. ;

Sureda, B. Massuti ;

Perrone, F. ;

McLachlan, S-A ;

Kang, J. H. ;

Wu, Y-l. ;

Dingemans, A-M C. ;

Dziadziuszko, R. ;

Okada, M. ;

Greillier, L. ;

Audigier-Valette, C. ;

Morin, F. ;

Sugawara, S. ;

Nadal, E. ;

Stockler, M. R. ;

Ding, K. ;

O'Callaghan, C. .

JOURNAL OF THORACIC ONCOLOGY, 2025, 20 (03) :S98-S99

[26] Patient-Reported Outcomes with Selpercatinib Among Patients with RET Fusion-Positive Non-Small Cell Lung Cancer in the Phase I/II LIBRETTO-001 Trial [J].

Minchom, Anna ;

Tan, Aaron C. ;

Massarelli, Erminia ;

Subbiah, Vivek ;

Boni, Valentina ;

Robinson, Bruce ;

Wirth, Lori J. ;

Hess, Lisa M. ;

Jen, Min-Hua ;

Kherani, Jennifer ;

Olek, Elizabeth ;

McCoach, Caroline E. .

ONCOLOGIST, 2022, 27 (01) :22-29

[27] Selpercatinib in Patients With RET Fusion-Positive Non-Small-Cell Lung Cancer: Updated Safety and Efficacy From the Registrational LIBRETTO-001 Phase I/II Trial [J].

Drilon, Alexander ;

Subbiah, Vivek ;

Gautschi, Oliver ;

Tomasini, Pascale ;

de Braud, Filippo ;

Solomon, Benjamin J. ;

Tan, Daniel Shao-Weng ;

Alonso, Guzman ;

Wolf, Juergen ;

Park, Keunchil ;

Goto, Koichi ;

Soldatenkova, Victoria ;

Szymczak, Sylwia ;

Barker, Scott S. ;

Puri, Tarun ;

Bence Lin, Aimee ;

Loong, Herbert ;

Besse, Benjamin .

JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (02) :385-+

[28] A phase 1b study of RXDX-105, a VEGFR-sparing potent RET inhibitor, in RETi-naive patients with RET fusion-positive NSCLC [J].

Drilon, A. E. ;

Liu, S. ;

Doebele, R. ;

Rodriguez, C. ;

Fakih, M. ;

Reckamp, K. L. ;

Bazhenova, L. ;

Cho, B. C. ;

Kowack, E. ;

Oliver, J. ;

Multani, P. ;

Ahn, M-J. .

ANNALS OF ONCOLOGY, 2017, 28

[29] Selpercatinib in RET Fusion-Positive Non-Small Cell Lung Cancer: Final Safety and Efficacy, Including Overall Survival, From the LIBRETTO-001 Phase I/II Trial [J].

Gautschi, Oliver ;

Park, Keunchil ;

Solomon, Benjamin J. ;

Tomasini, Pascale ;

Loong, Herbert H. ;

De Braud, Filippo ;

Goto, Koichi ;

Peterson, Patrick ;

Barker, Scott ;

Liming, Katherine ;

Oxnard, Geoffrey R. ;

Frimodt-Moller, Bente ;

Drilon, Alexander .

JOURNAL OF CLINICAL ONCOLOGY, 2025, 43 (15) :1758-1764

[30] Phase Ib study of neoadjuvant concurrent chemoradiation plus durvalumab followed by surgery and adjuvant durvalumab for resectable stage III NSCLC. [J].

Lee, Jiyun ;

Cho, Jaeho ;

Lee, Chang ;

Lee, Chang Young ;

Lee, Jin Gu ;

Kim, Dae Joon ;

Shim, Hyo Sup ;

Lim, Sun Min ;

Kim, Hye Ryun ;

Cho, Byoung Chul ;

Hong, Min Hee .

JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)

← 1 2 3 4 5 →